Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

Marianna Adamo, Ovidiu Chioncel, Matteo Pagnesi, Antoni Bayes-Genis, Magdy Abdelhamid, Stefan D Anker, Elena-Laura Antohi, Luigi Badano, Tuvia Ben Gal, Michael Böhm, Victoria Delgado, Julien Dreyfus, Francesco F Faletra, Dimitrios Farmakis, Gerasimos Filippatos, Julia Grapsa, Finn Gustafsson, Jörg Hausleiter, Tiny Jaarsma, Nicole KaramLars Lund, Philipp Lurz, Francesco Maisano, Brenda Moura, Wilfred Mullens, Fabien Praz, Anna Sannino, Gianluigi Savarese, Carlo Gabriele Tocchetti, Vanessa P M van Empel, Ralph Stephan von Bardeleben, Mehmet Birhan Yilmaz, José Luis Zamorano, Piotr Ponikowski, Emanuele Barbato, Giuseppe M C Rosano, Marco Metra*

*Corresponding author af dette arbejde
4 Citationer (Scopus)

Abstract

Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate aetiology and pathophysiological mechanisms leading to right-sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options. The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right-sided heart failure providing practical suggestions for patient identification and management.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Heart Failure
Vol/bind26
Udgave nummer1
Sider (fra-til)18-33
Antal sider16
ISSN1388-9842
DOI
StatusUdgivet - jan. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC'. Sammen danner de et unikt fingeraftryk.

Citationsformater